

Fundamental dimension Equity attribute | VICIPeer $23.76▼-1.08% Cap $26.16BP/E 9.2x QuantScore54/100 | EPRLeader $55.97▼-0.69% Cap $4.29BP/E 17.8x QuantScore56/100 | GLPIPeer $39.55▼-1.17% Cap $11.51BP/E 11.5x QuantScore52/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
64/100 |
71/100 |
64/100 |
Valuation Multiples, PEG & DCF upside | 97/100 | 92/100 | 95/100 |
Health Piotroski, Altman Z, leverage & liquidity | 24/100 | 16/100 | 32/100 |
Growth Revenue / earnings growth & margins | 42/100 | 51/100 | 30/100 |
Sentiment Analyst ratings, targets & revisions | 46/100 | 52/100 | 40/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 9.2x | 17.8x | 11.5x |
Forward P/E (next FY) | 8.6x | 18.3x | 12.2x |
EV / EBITDA (TTM) | 12.0x | 13.3x | 11.8x |
Price / Sales | 6.4x | 5.9x | 7.0x |
Price / Free Cash Flow | 9.9x | 18.3x | 18.3x |
PEG ratio | -8.01 | 0.34 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 5 / 9 | 4 / 9 |
Altman Z-Score | 1.26 (Distress) | 0.85 (Distress) | 1.27 (Distress) |
Total debt / equity | 0.61 | 1.53 | 1.68 |
Quick ratio | 0.4x | — | 9.4x |
Interest coverage | 4.3x | 2.9x | 3.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +4.1% | +12.1% | +4.1% |
Net income growth YoY | +3.6% | +88.2% | +5.2% |
Gross margin (TTM) | 99.3% | 69.6% | 47.0% |
Operating margin (FY) | 91.2% | 52.5% | 75.3% |
FCF margin (FY) | 62.6% | 58.6% | 51.7% |
5. Trailing price performancePrice change over period |
1M return | +2.1% | -1.5% | +2.6% |
3M return | -11.1% | -11.9% | -12.4% |
6M return | -16.4% | +0.8% | -16.4% |
Year to date | -15.5% | +12.2% | -11.5% |
1Y return | -23.8% | +4.1% | -11.7% |
3Y return | -15.0% | +34.9% | -13.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $128.43 +440.5% upside | $209.69 +274.6% upside | $130.14 +229.1% upside |
Wall Street consensus target | $28.73 +20.9% · range $24.00–$32.00 | $65.50 +17.0% · range $61.00–$70.50 | $48.00 +21.4% · range $43.00–$55.00 |
Consensus stance | 75% Buy25% Hold0% Sell | 32% Buy59% Hold9% Sell | 64% Buy29% Hold7% Sell |